Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • CDK
    (7)
  • GSK-3
    (7)
  • Apoptosis
    (3)
  • FLT
    (1)
  • Ferroptosis
    (1)
  • IGF-1R
    (1)
  • JNK
    (1)
  • Lipoxygenase
    (1)
  • MRP
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

indirubin

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    12
    TargetMol | All_Pathways
  • Natural Products
    3
    TargetMol | Natural_Products
Indirubin
NSC 105327, Indigopurpurin, Indigo red, Couroupitine B
T6169479-41-4
Indirubin (Couroupitine B) is a potent inhibitor of cyclin-dependent kinases and GSK-3β, with IC50 values of approximately 5 µM and 0.6 µM, respectively.
  • $45
In Stock
Size
QTY
Indirubin-3′-oxime
Indirubin-3'-monoxime
T9138667463-82-3
Indirubin-3′-oxime is an effective inhibitor of cyclin-dependent protein kinases, and may play an obligate role in neuronal apoptosis in Alzheimer's disease.
  • $39
In Stock
Size
QTY
Indirubin-3'-monoxime-5-sulphonic acid
T11652331467-05-1
Indirubin-3'-monoxime-5-sulphonic acid is a potent and selective inhibitor of GSK-3β, CDK5, and CDK1, with IC50s of 80 nM, 5 nM, and 7 nM, respectively.
  • $1,520
6-8 weeks
Size
QTY
Indirubin-5-sulfonate
T11653244021-67-8
Indirubin-5-sulfonate shows inhibitory activity against GSK-3β. Indirubin-5-sulfonate is a cyclin-dependent kinase (CDK) inhibitor, with IC50 values of 55 nM, 35 nM, 150 nM, 300 nM and 65 nM for CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK4/cyclin D1,
  • $1,520
6-8 weeks
Size
QTY
5-Iodo-indirubin-3'-monoxime
T10172331467-03-9In house
5-Iodo-indirubin-3'-monoxime is a potent inhibitor of GSK-3β, CDK5/P25, and CDK1/cyclin B, competing with ATP for binding to the catalytic site of the kinase (IC50s: 9, 20, and 25 nM).
  • $297
6-8 weeks
Size
QTY
Indirubin Derivative E804
T11654854171-35-0In house
Indirubin Derivative E804 is a potent insulin-like growth factor type 1 receptor (IGF1R) inhibitor with potential antitumor activity.
  • $37
In Stock
Size
QTY
Indirubin-3'-monoxime
Indirubin-3'-oxime
T5200160807-49-8
Indirubin-3'-monoxime (Indirubin-3'-oxime) is a potent inhibitor of GSK3β (IC50: 22 nM) and also inhibits CDKs ( (IC50s: 100/180/250 nM for Cdk5/p35, Cdk1/cyclin B, Cdk2/cyclin E).
  • $30
In Stock
Size
QTY
Meisoindigo
N-Methylisoindigotin, Natura-α, Methylisoindigotin, Dian III
T188297207-47-1
Meisoindigo (Natura-α) is a derivative of indigo natural, might induces apoptosis and myeloid differentiation of acute myeloid leukemia (AML).
  • $64
In Stock
Size
QTY
TargetMol | Citations Cited
Indican
NSC-87517, NSC87517, NSC 87517, Indoxyl-β-D-glucoside, 3-Indoxyl-beta-D-glucopyranoside
T19866487-60-5
Indican (Indoxyl-β-D-glucoside) is a natural protective compound that is used to protect the liver.
  • $31
In Stock
Size
QTY
5'-Fluoroindirubinoxime
5'-FIO
T8317861214-33-7
5'-Fluoroindirubinoxime (5'-FIO) is a potent FLT3 inhibitor( IC50 : 15 nM).
  • $42
In Stock
Size
QTY
GSK 3 Inhibitor IX
MLS 2052, GSK 3 IX, BIO, 6-bromoindirubin-3-oxime, 6-Bromoindirubin-3'-oxime, 6-BIO
T1917667463-62-9
GSK 3 Inhibitor IX (6-BIO) is a selective reversible, ATP-competitive inhibitor of GSK-3α/β and CDK1-cyclinB complex. It inhibits (GSK-3α/β)/CDK1/CDK5 activity with IC50 values of 5 nM/320 nM/83 nM, respectively.
  • $37
In Stock
Size
QTY
TargetMol | Citations Cited
GPX4-IN-7
T79777
GPX4-IN-7 (Compound 31), an indirubin derivative, serves as a ferroptosis inducer in colon cancer treatment. Exhibiting potent antitumor properties, it inhibits HCT-116 cell growth with an IC50 of 0.49 μM. This compound also facilitates GPX4 degradation, leading to lipid ROS accumulation, thereby inducing ferroptosis [1].
  • Inquiry Price
Inquiry
Size
QTY